Overview
QTRX market data
Price History
QTRX price chart · 1M
- O
- 2.67
- H
- 2.72
- L
- 2.63
- C
- 2.67
- Vol
- 19,725.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.67
- Previous Close
- $2.67
- Day High
- $2.72
- Day Low
- $2.63
- 52 Week High
- $4.57
- 52 Week Low
- $2.16
- 7 Day Return
- -14.29%
- 30 Day Return
- -23.50%
- 90 Day Return
- -12.75%
- 1 Year Return
- -12.46%
- Daily Notional Volume
- $52.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.51 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.05 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -71.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.15 – $8.77 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $136.7M · P/B 1.00 · P/S 0.94.
Company News
Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsightGlobenewswire Inc · Aug 27, 2026, 5:30 PM
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · Aug 24, 2026, 1:28 PM
Canaccord Genuity Maintains Hold on Quanterix, Lowers Price Target to $3Benzinga · Aug 17, 2026, 12:24 PM
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $3Benzinga · Aug 11, 2026, 4:05 PM
CORRECTION: Quanterix Q2 Adj. EPS $(0.47) Misses $(0.46) Estimate, Sales $32.906M Miss $37.462M EstimateBenzinga · Aug 10, 2026, 2:34 PM
Quanterix shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 10, 2026, 1:28 PM
8-K filing — Quanterix Corp (QTRX)SEC EDGAR · Aug 10, 2026, 12:07 PM
Quanterix Q2 EPS $(1.04) Misses $(0.40) Estimate, Sales $32.906M Miss $37.462M EstimateBenzinga · Aug 10, 2026, 12:03 PM
Quanterix Lowers FY2026 Sales Guidance from $169.000M-$174.000M to $142.000M-$148.000M vs $169.930M EstBenzinga · Aug 10, 2026, 12:00 PM
Quanterix Announces Milestones Advancing Clinical Adoption Of Blood-Based Alzheimer's TestingBenzinga · Jul 14, 2026, 8:34 PM